123I-FP-CIT SPECT in the differential diagnosis between dementia with Lewy bodies and other dementias

Journal of the Neurological Sciences

Volumn 359, Issue 1-2, 2015, Pages 161-171

  Brigo, Francesco ^a,b   Turri, Giulia ^a   Tinazzi, Michele ^a  

^a UNIVERSITY OF VERONA   (Italy)

^b 'F Tappeiner' Hospital   (Italy)

Author keywords

123I FP CIT single photon emission computed tomography; Alzheimer's disease; Dementia with Lewy bodies; Meta analysis; Sensitivity; Specificity

Indexed keywords

IOFLUPANE I 123; 2-CARBOMETHOXY-8-(3-FLUOROPROPYL)-3-(4-IODOPHENYL)TROPANE; TROPANE DERIVATIVE;

ARTICLE; BRAIN REGION; DEMENTIA; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DIFFUSE LEWY BODY DISEASE; DOPAMINERGIC SYSTEM; FRONTOTEMPORAL DEMENTIA; HUMAN; META ANALYSIS; NEUROIMAGING; PARKINSON DISEASE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REFERENCE DATABASE; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SYSTEMATIC REVIEW; SCINTISCANNING;

DEMENTIA; DIAGNOSIS, DIFFERENTIAL; HUMANS; LEWY BODY DISEASE; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TROPANES;

EID: 84949653663     PISSN: 0022510X     EISSN: 18785883     Source Type: Journal    
DOI: 10.1016/j.jns.2015.11.004     Document Type: Review

References (48)

1. J. Zaccai, C. McCracken, and C. Brayne A systematic review of prevalence and incidence studies of dementia with Lewy bodies Age Ageing 34 2005 561 566
2. I.G. McKeith, D. Galasko, K. Kosaka, E.K. Perry, D.W. Dickson, L.A. Hansen, and et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop Neurology 47 1996 1113 1124
3. I.G. McKeith, D.W. Dickson, J. Lowe, M. Emre, J.T. O'Brien, H. Feldman, J. Cummings, J.E. Duda, C. Lippa, E.K. Perry, D. Aarsland, H. Arai, C.G. Ballard, B. Boeve, D.J. Burn, D. Costa, T. Del Ser, B. Dubois, D. Galasko, S. Gauthier, C.G. Goetz, E. Gomez-Tortosa, G. Halliday, L.A. Hansen, J. Hardy, T. Iwatsubo, R.N. Kalaria, D. Kaufer, R.A. Kenny, A. Korczyn, K. Kosaka, V.M. Lee, A. Lees, I. Litvan, E. Londos, O.L. Lopez, S. Minoshima, Y. Mizuno, J.A. Molina, E.B. Mukaetova-Ladinska, F. Pasquier, R.H. Perry, J.B. Schulz, J.Q. Trojanowski, and M. Yamada Consortium on DLB. Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium Neurology 65 2005 1863 1872
4. I. McKeith, A. Fairbairn, R. Perry, P. Thompson, and E. Perry Neuroleptic sensitivity in patients with senile dementia of Lewy body type BMJ 305 1992 673 678
5. C. Ballard, J. Grace, I. McKeith, and C. Holmes Neuroleptic sensitivity in dementia with Lewy bodies and Alzheimer's disease Lancet 351 1998 1032 1033
6. D. Aarsland, R. Perry, J.P. Larsen, I.G. McKeith, J.T. O'Brien, E.K. Perry, D. Burn, and C.G. Ballard Neuroleptic sensitivity in Parkinson's disease and parkinsonian dementias J. Clin. Psychiatry 66 2005 633 637
7. I. McKeith, T. Del Ser, P. Spano, M. Emre, K. Wesnes, R. Anand, A. Cicin-Sain, R. Ferrara, and R. Spiegel Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study Lancet 356 2000 2031 2036
8. K. Ukai, H. Fujishiro, S. Iritani, and N. Ozaki Long-term efficacy of donepezil for relapse of visual hallucinations in patients with dementia with Lewy bodies Psychogeriatrics 2014 10.1111/psyg.12089
9. H.F. Wang, J.T. Yu, S.W. Tang, T. Jiang, C.C. Tan, X.F. Meng, C. Wang, M.S. Tan, and L. Tan Efficacy and safety of cholinesterase inhibitors and memantine in cognitive impairment in Parkinson's disease, Parkinson's disease dementia, and dementia with Lewy bodies: systematic review with meta-analysis and trial sequential analysis J. Neurol. Neurosurg. Psychiatry 86 2015 135 143
10. I. McKeith, J. Mintzer, D. Aarsland, D. Burn, H. Chiu, J. Cohen-Mansfield, D. Dickson, B. Dubois, J.E. Duda, H. Feldman, S. Gauthier, G. Halliday, B. Lawlor, C. Lippa, O.L. Lopez, J. Carlos Machado, J. O'Brien, J. Playfer, W. Reid, and International Psychogeriatric Association Expert Meeting on DLB Dementia with Lewy bodies Lancet Neurol. 3 2004 19 28
11. D. Weisman, and I. McKeith Dementia with Lewy bodies Semin. Neurol. 27 2007 42 47
12. I. McKeith, J. O'Brien, Z. Walker, K. Tatsch, J. Booij, J. Darcourt, A. Padovani, R. Giubbini, U. Bonuccelli, D. Volterrani, C. Holmes, P. Kemp, N. Tabet, I. Meyer, C. Reininger, and DLB Study Group Sensitivity and specificity of dopamine transporter imaging with 123I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre study Lancet Neurol. 6 2007 305 313
13. National Institute for Health and Clinical Excellence and Social Care Institute for Excellence. A NICE-SCIE Guideline on supporting people with dementia and their carers in health and social care. 2007. Available online at: http://www.nice.org.uk/guidance/cg42/evidence/cg42-dementia-full-guideline-including-appendices-172 [Accessed July 13, 2015].
14. P.F. Whiting, A.W. Rutjes, M.E. Westwood, S. Mallett, J.J. Deeks, J.B. Reitsma, M.M. Leeflang, J.A. Sterne, P.M. Bossuyt, and QUADAS-2 Group QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies Ann. Intern. Med. 18 2011 529 536
15. M. Egger, G.D. Smith, and D.G. Altman Systematic Reviews in Health Care 2005 BMJ Publishing Group London
16. D.R. Cox The Analysis of Binary Data 1970 Methuen London
17. S.R. McGee Diagnostic accuracy of physical findings S.R. McGee, Evidence-Based Physical Diagnosis 2007 Saunders Elsevier
18. Zamora J, Muriel A, Abraira V. (2006) Statistical methods. 2006a Available at: ftp://ftp.hrc.es/pub/programas/metadisc/MetaDisc-StatisticalMethods.pdf (accessed 20th March 2015).
19. D.L. Simel, G.P. Samsa, and D.B. Matchar Likelihood ratios with confidence: sample size estimation for diagnostic test studies J. Clin. Epidemiol. 44 1991 763 770
20. R.G. Newcombe Two-sided confidence intervals for the single proportion: comparison of seven methods Stat. Med. 17 1998 857 872
21. W.L. Devillé, F. Buntinx, L.M. Bouter, V.M. Montori, H.C. de Vet, D.A. van der Windt, and P.D. Bezemer Conducting systematic reviews of diagnostic studies: didactic guidelines BMC Med. Res. Methodol. 2 2002 9
22. J. Zamora, V. Abraira, A. Muriel, K.S. Khan, and A. Coomarasamy Meta-DiSc: a software for meta-analysis of test accuracy data BMC Med. Res. Methodol. 6 2006 31
23. R. DerSimonian, and N. Laird Meta-analysis in clinical trials Control. Clin. Trials 7 1986 177 188
24. J.P. Higgins, S.G. Thompson, J.J. Deeks, and D.G. Altman Measuring inconsistency in meta-analyses BMJ 327 2003 557 560
25. J.T. O'Brien, S. Colloby, J. Fenwick, E.D. Williams, M. Firbank, D. Burn, D. Aarsland, and I.G. McKeith Dopamine transporter loss visualized with FP-CIT SPECT in the differential diagnosis of dementia with Lewy bodies Arch. Neurol. 61 2004 919 925
26. S.J. Colloby, M.J. Firbank, S. Pakrasi, J.J. Lloyd, I. Driver, I.G. McKeith, E.D. Williams, and J.T. O'Brien A comparison of 99mTc-exametazime and 123I-FP-CIT SPECT imaging in the differential diagnosis of Alzheimer's disease and dementia with Lewy bodies Int. Psychogeriatr. 20 2008 1124 1140
27. R.W. Walker, and Z. Walker Dopamine transporter single photon emission computerized tomography in the diagnosis of dementia with Lewy bodies Mov. Disord. 24 2009 S754 S759
28. P.M. Kemp, K. Clyde, and C. Holmes Impact of 123I-FP-CIT (DaTSCAN) SPECT on the diagnosis and management of patients with dementia with Lewy bodies: a retrospective study Nucl. Med. Commun. 32 2011 298 302
29. S. Morgan, P. Kemp, J. Booij, D.C. Costa, S. Padayachee, L. Lee, C. Barber, J. Carter, and Z. Walker Differentiation of frontotemporal dementia from dementia with Lewy bodies using FP-CIT SPECT J. Neurol. Neurosurg. Psychiatry 83 2012 1063 1070
30. J.T. O'Brien, W.H. Oertel, I.G. McKeith, D.G. Grosset, Z. Walker, K. Tatsch, E. Tolosa, P.F. Sherwin, and I.D. Grachev Is ioflupane I123 injection diagnostically effective in patients with movement disorders and dementia? Pooled analysis of four clinical trials BMJ Open 4 2014 e005122
31. G. Treglia, E. Cason, P. Cortelli, A. Gabellini, R. Liguori, A. Bagnato, A. Giordano, and G. Fagioli Iodine-123 metaiodobenzylguanidine scintigraphy and iodine-123 ioflupane single photon emission computed tomography in Lewy body diseases: complementary or alternative techniques? J. Neuroimaging 24 2014 149 154
32. T.S. Spehl, L. Frings, S. Hellwig, C. Weiller, M. Hüll, P.T. Meyer, and F. Amtage Role of semiquantitative assessment of regional binding potential in 123I-FP-CIT SPECT for the differentiation of frontotemporal dementia, dementia with Lewy bodies, and Alzheimer's dementia Clin. Nucl. Med. 40 2015 e27 e33
33. Z. Walker, D.C. Costa, R.W. Walker, K. Shaw, S. Gacinovic, T. Stevens, G. Livingston, P. Ince, I.G. McKeith, and C.L. Katona Differentiation of dementia with Lewy bodies from Alzheimer's disease using a dopaminergic presynaptic ligand J. Neurol. Neurosurg. Psychiatry 73 2002 134 140
34. Z. Walker, E. Jaros, R.W. Walker, L. Lee, D.C. Costa, G. Livingston, P.G. Ince, R. Perry, I. McKeith, and C.L. Katona Dementia with Lewy bodies: a comparison of clinical diagnosis. FP-CIT single photon emission computed tomography imaging and autopsy J. Neurol. Neurosurg. Psychiatry 78 2007 1176 1181
35. S.S. Mirra, A. Heyman, D. McKeel, S.M. Sumi, B.J. Crain, L.M. Brownlee, F.S. Vogel, J.P. Hughes, G. van Belle, and L. Berg The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease Neurology 41 1991 479 486
36. H. Braak, and E. Braak Neuropathological stageing of Alzheimer-related changes Acta Neuropathol. (Berl) 82 1991 239 259
37. M.J. Ball, and G.H. Murdoch Neuropathological criteria for the diagnosis of Alzheimer's disease: are we really ready yet? Neurobiol. Aging 18 1997 S3 12
38. J.T. O'Brien, M.K. IG, Z. Walker, K. Tatsch, J. Booij, J. Darcourt, M. Marquardt, C. Reininger, and DLB Study Group Diagnostic accuracy of 123I-FP-CIT SPECT in possible dementia with Lewy bodies Br. J. Psychiatry 194 2009 34 39
39. D. Neary, J.S. Snowden, L. Gustafson, U. Passant, D. Stuss, S. Black, M. Freedman, A. Kertesz, P.H. Robert, M. Albert, K. Boone, B.L. Miller, J. Cummings, and D.F. Benson Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria Neurology 51 1998 1546 1554
40. Reitsma JB, Rutjes AWS, Whiting P, Vlassov VV, Leeflang MMG, Deeks JJ,. (2009) Chapter 9: assessing methodological quality. In: Deeks JJ, Bossuyt PM, Gatsonis C (editors), Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy Version 1.0.0. The Cochrane Collaboration, 2009. Available online at: http://srdta.cochrane.org/sites/srdta.cochrane.org/files/uploads/ch09-Oct09.pdf [Accessed July 13, 2015].
41. P. Piccini, and A. Whone Functional brain imaging in the differential diagnosis of Parkinson's disease Lancet Neurol. 3 2004 284 290
42. C. Scherfler, J. Schwarz, A. Antonini, D. Grosset, F. Valldeoriola, K. Marek, W. Oertel, E. Tolosa, A.J. Lees, and W. Poewe Role of DAT-SPECT in the diagnostic work up of parkinsonism Mov. Disord. 15 2007 1229 1238
43. A. Berardelli, G.K. Wenning, A. Antonini, D. Berg, B.R. Bloem, V. Bonifati, D. Brooks, D.J. Burn, C. Colosimo, A. Fanciulli, J. Ferreira, T. Gasser, F. Grandas, P. Kanovsky, V. Kostic, J. Kulisevsky, W. Oertel, W. Poewe, J.P. Reese, M. Relja, E. Ruzicka, A. Schrag, K. Seppi, P. Taba, and M. Vidailhet EFNS/MDS-ES/ENS [corrected] recommendations for the diagnosis of Parkinson's disease Eur. J. Neurol. 20 2013 16 34
44. F. Brigo, A. Matinella, R. Erro, and M. Tinazzi [1I]FP-CIT SPECT (DaTSCAN) may be a useful tool to differentiate between Parkinson's disease and vascular or drug-induced parkinsonisms: a meta-analysis Eur. J. Neurol. 21 2014 369-e90
45. A. Antonini The role of I-ioflupane SPECT dopamine transporter imaging in the diagnosis and treatment of patients with dementia with Lewy bodies Neuropsychiatr. Dis. Treat. 3 2007 287 292
46. P.T. Nelson, G.A. Jicha, R.J. Kryscio, E.L. Abner, F.A. Schmitt, G. Cooper, and et al. Low sensitivity in clinical diagnoses of dementia with Lewy bodies J. Neurol. 257 2010 359 366
47. 123I-FP-CIT (DaTSCAN) in dementia with Lewy bodies: a meta-analysis of published studies Parkinsonism Relat. Disord. 18 2012 225 229
48. J. McCleery, S. Morgan, K.M. Bradley, A.H. Noel-Storr, O. Ansorge, and C. Hyde Dopamine transporter imaging for the diagnosis of dementia with Lewy bodies Cochrane Database Syst. Rev. 1 2015 Jan 30 CD010633 10.1002/14651858.CD010633.pub2